Company / Operating Cash Flow
CONMED Corporation Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$170.7M
FY2025
5-year range
$33.4M / $170.7M
FY2021-FY2025
Trend
+2.2%
vs FY2024
Sector context
#92 of 163
Health Care
What the data says
At $171M, CONMED Corporation's operating cash flow ranks #92 of 163 in the Health Care sector. Operating Cash Flow has increased for 3 consecutive years, from $33M in FY2022 to $171M in FY2025.
Based on SEC 10-K filings.
$171M in FY2025 with a 5-year CAGR of +21.5%.
Improved from $125M to $171M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +72.3%
- 5-Year CAGR
- +21.5%
- 10-Year CAGR
- -
Sector benchmark
#92 of 163 in Health CareTop 56% of 163This company $170.7M Sector average $1.0B
▼
-83.7% below sector average
Key checks
Key Insights
- CONMED Corporation's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +21.5%, indicating consistent growth.
- In FY2025, operating cash flow increased 2.2% year-over-year.
- Ranks #92 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $170.7M | +2.2% |
| FY2024 | $167.0M | +33.2% |
| FY2023 | $125.3M | +275.7% |
| FY2022 | $33.4M | -70.1% |
| FY2021 | $111.8M | +73.2% |
| FY2020 | $64.5M | -32.2% |
| FY2019 | $95.1M | +27.4% |
| FY2018 | $74.7M | +13.9% |
| FY2017 | $65.6M | +64.4% |
| FY2016 | $39.9M | -21.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026